NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Lise Estcourt
University of Oxford - Oxford / United Kingdom
Medical and Health Sciences / Hematology
AD Scientific Index ID: 5004847
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Lise Estcourt's MOST POPULAR ARTICLES
1-)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialRECOVERY Collaborative GroupLancet (London, England) 397 (10285), 1637, 20211800*2021
2-)
Interleukin-6 receptor antagonists in critically ill patients with Covid-19Remap-Cap InvestigatorsNew England Journal of Medicine 384 (16), 1491-1502, 202117152021
3-)
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trialDC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ...Jama 324 (13), 1317-1329, 2020
4-)
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19ATTACC, ACTIV-4a, and REMAP-CAP InvestigatorsNew England Journal of Medicine 385 (9), 790-802, 2021
5-)
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 399 (10325), 665-676, 2022
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept